+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Nanotechnology Drug Delivery Market: By Technology, By Application & By Region - Forecast 2017-2022

  • ID: 3973831
  • Report
  • 146 pages
  • IndustryARC
1 of 2
Nanotechnology Drug Delivery mainly used in healthcare applications such as such as neurology, anti-infective, cardiovascular disorders, and others. They are part of active application of the transport drugs to the final location of therapeutic intervention within the body. Globally, development of efficient and advance technology, expanding nanotechnology research, growing awareness among common people, increasing government initiatives, and rising demand for novel drug delivery are the prime growth drivers of global Nanotechnology Drug Delivery market. In addition, increase in adoption of Nanotechnology Drug Delivery for in emerging economies such as China, India and others, will create new opportunities for global Nanotechnology Drug Delivery market. However, higher cost of the research and development, high cost of production with stringent regulatory scenario are the key restraints for global Nanotechnology Drug Delivery market.

Geographically North America dominated global Nanotechnology Drug Delivery market, because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the application, neurology procedures has the highest market share in global Nanotechnology Drug Delivery market.

This report identifies the global Nanotechnology Drug Delivery market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Nanotechnology Drug Delivery market.

This report segments global Nanotechnology Drug Delivery market on the basis of technology, application, and regional market as follows:

Nanotechnology Drug Delivery Market, By Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others
The report has focused study on Nanotechnology Drug Delivery market by application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Nanotechnology Drug Delivery market. Some of the major companies’ profiles in detail are as follows:

AbbVie, Inc
Amgen, Inc
Celgene Corporation
Johnson & Johnson
Merck & Co., Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Nanotechnology Drug Delivery Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Nanotechnology Drug Delivery Market– Market Forces
4.1. Drivers
4.1.1. Development of efficient and advance technology
4.1.2. Expanding nanotechnology research
4.1.3. Rising demand for novel drug delivery
4.2. Restraints
4.2.1. High cost of production
4.2.2. Stringent regulatory scenario
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Nanotechnology Drug Delivery Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Nanotechnology Drug Delivery Market, By Technology
6.1. Nanocrystals
6.2. Nanoparticles
6.3. Liposomes
6.4. Micelles
6.5. Nanotubes
6.6. Others

7. Nanotechnology Drug Delivery Market, By Application
7.1. Neurology
7.2. Oncology
7.3. Cardiovascular/Physiology
7.4. Anti-inflammatory/Immunology
7.5. Anti-infective,
7.6. Others

8. Nanotechnology Drug Delivery Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Nanotechnology Drug Delivery – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. AbbVie, Inc
10.2. Amgen, Inc
10.3. Celgene Corporation
10.4. Johnson & Johnson
10.5. Merck & Co., Inc
10.6. Novartis International AG
10.7. 3M company
10.8. AMSC Corporation
10.9. Agilent Technologies Inc
10.10. Bayer AG.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 2